Open Access

The 1st call for the Open Access is now closed. The 2nd call will open in February 2026. 

The Alliance4Life member institutions offer access to technologies and services in the field of life sciences to study biologically important cellular components and macromolecules – proteins, nucleic acids, and their complexes at different resolution levels, ranging from atomic to cellular.

Who can use our services?

The call is intented only for Alliance4Life project partners, not for companies or external academics.

If you are commercial partner interested to use the infrastructure listed in the database please feel free to contact core facilities and shared laboratories to inquire about the specific services you plan to use. We will gladly prepare a customized quotation based on your requirements. Contact information of core facilities and shared laboratories can be found in the database of services offered.

1st Call

This call is now closed. See the important documents and results below.


Important documents

Find the the documents necessary for successful reporting:

  • Call for proposals
  • Application Form
  • Final Report

Results of the Call

The following projects have been selected for the open access: 

University of Ljubljana

  • Spatial characterization of biochemical and micromechanical alterations in deep fascia in type 2 diabetes mellitus using Raman-AFM combined microscopy.
    • Contact: Chiedozie Kenneth Ugwoke
  • Unravelling the mechanisms of PLEC expression and release from wild-type and IF-null astrocytes.
    • Contact: Borut Furlani

Biomedical Research Center SAS

  • Oxidative stress during metabolic cycle on DNA Transcription in yeast
    • Contact: Miloslav Karhánek
  • Deciphering Cancer-Associated Fibroblast-Mediated Mechanisms Underlying the Effects of Combination Therapy Integrating DNMT Inhibitor Decitabine with Chemotherapy in PDAC
    • Contact: Maria Urbanova
  • Detection of corridors and associated structures during apocrine secretion in Drosophila.
    • Contact: Milan Beňo
  • Next-Generation Sequencing in Syndromic Hearing Loss Diagnostics
    • Contact: Silvia Borecka
  • Validation of identified MASLD-specific EVs surface proteins by Atomic force microscopy (AFM)
    • Contact: Zuzana Vince Kážmérová
  • Validation of identified MASLD-specific EVs surface proteins by Atomic force microscopy (AFM)
    • Contact: Zuzana Vince Kážmérová
  • Expression of immune genes in human skin non-immune cells affected by TBEV infection
    • Contact: Iveta Štibrániová
  • Identification of lncRNA Biomarkers for Metastatic Potential in Colorectal Cancer through RNA Expression Profiling
    • Contact: Martina Poturnajova
  • The role and mutational profile of immune checkpoint molecules in hematologic malignancies.
    • Contact: Katarína Lopušná
  • Examining the myeloma secretome in plasma through proteomic approaches
    • Contact: Jana Jakubikova
  • Identification of TGF-β 1 binding molecule(s) in saliva of adult ticks Dermacentor reticulatus.
    • Contact: Pavlína Bartíková

St. Anne's University Hospital Brno/ICRC

  • Modulating mitochondrial functions and mitophagy in glioblastoma cells and astrocytes
    • Contact: Victorio Pozo Devoto

University of Tartu

  • Data acquisition and analysis of organelle transport in 3D organs via in vivo live imaging
    • Contact: Juhan Pikamäe
  • Uncovering how depression and anxiety may increase risk of Parkinson’s disease
    • Contact: Miriam Hickey
  • Analysis of eukaryotic ribosomal protein cleavage by viral protease
    • Contact: Zuzana Vince Kážmérová

School of Medicine - University of Zagreb

  • Proteome DiSScovery: Proteomic study of blood plasma and extracellular vesicles in Interstitial lung disease associated with Systemic Sclerosis
    • Contact: Stela Hrkač
  • Epigenetic profiling of human cerebral organoids – E-pro-Org
    • Contact: Jure Krasić
  • The role of microRNAs in the diagnosis of kidney transplant antibody-mediated rejection and acute tubular necrosis
    • Contact: Petar Šenjug
2nd Call

This call is not yet open. It will open in February 2026

You are running an old browser version. We recommend updating your browser to its latest version.

More info